Bastas takes control of Juno as Arrotex profits go through roof

New operation DGB Health to control both generic pharmacos in reputed $1 billion deal, according to finance media One of Australia’s richest individuals Dennis Bastas is now in control of both Arrotex and Juno Pharmaceuticals as the result of a $1 billion deal completed in July, according to the Australian Financial Review. Bastas, who regularly